The Sixth Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium is dedicated to important clinical topics relevant to cardiomyopathy and cardiovascular health of cancer survivors.
The Sixth Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium covers topics such as:
- Strategies for early detection, correction of cardiac risk factors, and close and long-term cardiac monitoring in order to reduce the effects of cardiotoxicity for patients who are at risk of cancer treatment-related cardiac dysfunction, including heart failure, valvular dysfunction and autonomic dysfunction
- The risks of oncologic treatment-related cardiac dysfunction for patients who have undergone therapy for cancer
- Critically multi-modality imaging such as cardiac magnetic resonance (MR), echocardiography, and nuclear imaging including positron emission tomography (PET) scanning in the diagnosis and follow -up of cardiomyopathy
- Potential cardiovascular complications of novel molecular targeted therapies, including arrhythmias, cardiomyopathy, cardiac ischemia, and hypertension
- Common clinical and diagnostic criteria that would prompt a detailed pulmonary hypertension evaluation
- Patient selection for advanced diagnostics for dyspnea
- The latest diagnosis and treatment options available for cardiac amyloidosis
- Recommendations from the recently updated ACC/AHA/Heart Failure Society of America (HFSA) guidelines when diagnosing and managing patients with cardiomyopathy
- Available clinical evidence for recommendations for the management of cardiovascular disease during pregnancy
- Guidelines and algorithms for the evaluation and management of patients with syncope, sudden cardiac death, and cardiac sarcoidosis based on current recommendations from the ACC/AHA/Heart Rhythm Society (HRS)
- The importance of the multidisciplinary cardio-oncology team
- Patients who would benefit from implantable pulmonary artery sensor monitoring
The Sixth Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium will be held in La Jolla on 23 September 2023.